Title |
Promotion of Prescription Drugs to Consumers and Providers, 2001–2010
|
---|---|
Published in |
PLOS ONE, March 2013
|
DOI | 10.1371/journal.pone.0055504 |
Pubmed ID | |
Authors |
Rachel Kornfield, Julie Donohue, Ernst R. Berndt, G. Caleb Alexander |
Abstract |
Pharmaceutical firms heavily promote their products and may have changed marketing strategies in response to reductions in new product approvals, restrictions on some forms of promotion, and the expanding role of biologic therapies. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
United Kingdom | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 103 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 17 | 16% |
Student > Bachelor | 16 | 15% |
Student > Ph. D. Student | 14 | 13% |
Researcher | 12 | 11% |
Student > Doctoral Student | 10 | 10% |
Other | 18 | 17% |
Unknown | 18 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 23 | 22% |
Business, Management and Accounting | 16 | 15% |
Social Sciences | 11 | 10% |
Agricultural and Biological Sciences | 9 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 7% |
Other | 17 | 16% |
Unknown | 22 | 21% |